Clinical Trial Update: Antiretroviral Therapy and Inflammatory and Coagulation Biomarkers: iMACS Study

View source ↗

Summary

Update on the iMACS trial evaluating antiretroviral therapy and its effects on inflammatory and coagulation biomarkers; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection
• Noncommunicable Diseases
• Tuberculosis

Drugs mentioned

• antiretroviral therapy (ART) (antiretroviral therapy)

Snippet

Sponsor: Columbia University | Conditions: HIV (Human Immunodeficiency Virus), AIDS (Acquired Immune Deficiency Syndrome) | Status: COMPLETED